Kaymak, C. Et Al. 2006. β2 adrenoceptor (ADRB2) pharmacogenetics and cardiovascular phenotypes during laryngoscopy and tracheal intubation. International Journal of Toxicology , vol.25, no.6 , 443-449.

Kaymak, C., Kocabas, N. A., Durmaz, E., & Oztuna, D., (2006). β2 adrenoceptor (ADRB2) pharmacogenetics and cardiovascular phenotypes during laryngoscopy and tracheal intubation. International Journal of Toxicology , vol.25, no.6, 443-449.

Kaymak, Cetin Et Al. "β2 adrenoceptor (ADRB2) pharmacogenetics and cardiovascular phenotypes during laryngoscopy and tracheal intubation," International Journal of Toxicology , vol.25, no.6, 443-449, 2006

Kaymak, Cetin Et Al. "β2 adrenoceptor (ADRB2) pharmacogenetics and cardiovascular phenotypes during laryngoscopy and tracheal intubation." International Journal of Toxicology , vol.25, no.6, pp.443-449, 2006

Kaymak, C. Et Al. (2006) . "β2 adrenoceptor (ADRB2) pharmacogenetics and cardiovascular phenotypes during laryngoscopy and tracheal intubation." International Journal of Toxicology , vol.25, no.6, pp.443-449.

@article{article, author={Cetin Kaymak Et Al. }, title={β2 adrenoceptor (ADRB2) pharmacogenetics and cardiovascular phenotypes during laryngoscopy and tracheal intubation}, journal={International Journal of Toxicology}, year=2006, pages={443-449} }